Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper

Super funds back COVID-19 preventative drug

Four major superannuation funds are backing a biotech company that is developing a nasal spray that claims to prevent COVID-19 and the common cold.

LoginGo Premium

Read more: Ena RespiratoryAustralianSuperBrandon CapitalChristophe DemaisonCSLHESTAHostplusStatewide Super